首页 | 本学科首页   官方微博 | 高级检索  
     


Real‐life clinical use of natalizumab and fingolimod in Austria
Authors:M. Guger  C. Enzinger  F. Leutmezer  J. Kraus  S. Kalcher  E. Kvas  T. Berger
Affiliation:1. Clinic for Neurology 2, Med Campus III., Kepler University Clinic, Linz, Austria;2. Department of Neurology, Medical University of Graz, Graz, Austria;3. Department of Neurology, Medical University of Vienna, Vienna, Austria;4. Department of Laboratory Medicine, Paracelsus Medical University and Salzburger Landeskliniken, Salzburg, Austria;5. Department of Neurology, Medical Faculty, Heinrich‐Heine‐University, Düsseldorf, Germany;6. Hermesoft, Data management, Graz, Austria;7. Hermesoft, Statistics, Graz, Austria;8. Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
Abstract:
Keywords:comparison  efficacy  fingolimod  multiple sclerosis  natalizumab  propensity score
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号